To investigate whether the systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) differ among patients with vestibular migraine (VM), patients with Meniere's disease (MD), and healthy controls, and to examine their associations with annual vertigo attack frequency and dizziness-related disability.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — the systemic immune-inflammation and prognostic nutritional indices are not yet validated clinical tools for diagnosing or managing vestibular migraine or Meniere's disease.
Identifying objective blood-based markers that differ between vestibular migraine and Meniere's disease could eventually aid in differential diagnosis, which is currently largely clinical and symptom-based.
- 01Systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) differed between vestibular migraine, Meniere's disease, and healthy controls.
- 02Retrospective design limits causal inference; results are exploratory.
- 03Suggests a potential role of systemic inflammation in both conditions.
- 04Could point toward future blood-test-assisted differential diagnosis of these overlapping disorders.
- 05Study is a retrospective comparison — larger prospective studies are needed.
SII and PNI values differ significantly between vestibular migraine, Meniere's disease, and healthy controls.
studypartially supportedSystemic inflammation and nutritional status may contribute to the pathophysiology of vestibular migraine and Meniere's disease.
studyunclear- PMID
- 42747533
- DOI
- 10.1007/s00405-026-10635-9.
- Journal
- European Archives of Oto-Rhino-Laryngology
- Publication type
- research_article
- Evidence level
- 3
- Population
- Adults with vestibular migraine, adults with Meniere's disease, and healthy controls
- Intervention
- Measurement of systemic immune-inflammation index (SII) and prognostic nutritional index (PNI)
- Comparator
- Healthy controls
Primary outcomes
Differences in SII and PNI across vestibular migraine, Meniere's disease, and healthy control groups